Company & Sponsor Intelligence

University of Pennsylvania

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials18

Recruiting5

Completed9

Countries1

Therapeutic footprint

adhdalzheimersautismdementia_otherepilepsyother_psychiatryparkinsonsstrokesubstance_use

Indexed studies

NCT03424811Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder
autism · United StatesNA

NCT03615079Internet-based CBT After Stroke Pilot
stroke · United StatesNA

NCT01756053Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
substance_use · United StatesPHASE2

NCT02978729Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial
alzheimers · NA

NCT02427672The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior
other_psychiatry · United StatesNA

NCT02463708Evaluation of the PACE/PACENET BHL Caregiver Program
dementia_other · United StatesENROLLING_BY_INVITATION

NCT00766038Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
dementia_other · United StatesPHASE2

NCT05277194Reducing Challenging Behaviors in Children With Autism Through Digital Health
autism · United StatesNA

NCT04729127A Trial of Project ImPACT in Early Intervention
autism · United StatesNA

NCT06915259Doula Model of Care
other_psychiatry · United StatesNA

NCT04897334Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
stroke · United StatesNA

NCT07489430DaxibotulinumtoxinA for Blepharospasm
parkinsons · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →